[Marketwired] - Titan Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has issued this evening a Complete Response Letter to its New Drug Application for Probuphine®, the company's investigational ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment